According to current guidelines, the surgical treatment of benign prostatic hyperplasia is main therapeutic option, being refractory conservative approach. Transurethral resection prostate and open transvesical adenomectomy have been considered a reference standard in medium (<80ml) large (> 80ml) hyperplasia. To reduce postoperative complications promote faster recovery, there proposed s...

OBJECTIVE Identify prognostic factors associated to late urinary toxicity in patients with prostate cancer submitted to radical conformal radiotherapy (3DCRT). MATERIALS AND METHODS From July 1997 to January 2002, 285 patients with localized prostate cancer were consecutively treated with 3DCRT and retrospectively analyzed. Thirty seven (13%) patients were submitted to transurethral prostate ...

OBJECTIVES To determine the preoperative, intraoperative and postoperative risk factors that influence the development of persistent post-transurethral resection of the prostate (TURP) urinary tract infection (UTI) defined as pyuria and/or bacteriuria remaining for 3 weeks after surgery. PATIENTS AND METHODS This is a prospective study including 100 patients scheduled for TURP. Urine analysis...

Background: Transurethral resection of the prostate (TURP) remains the Gold Standard surgical treatment of Benign Prostate Enlargement. Hemorrhage during and after TURP can lead to significant morbidity and occasionally prove fatal. Objective: Our study aimed to evaluate the trend of blood loss in transurethral resection of the prostate for patients who presented with benign prostate enlargemen...

Benign prostatic hyperplasia (BPH) is one of the most common diseases in middle-aged and elderly men. In the present study, we aimed to compare the efficacy and safety of thulium laser resection of the prostate (TMLRP) with either transurethral plasmakinetic resection of the prostate (TUPKP) or transurethral resection of the prostate (TURP). A literature search was performed, eventually, 14 stu...

Introduction: Benign prostatic hypertrophy (BPH) is a very common urological pathology and occurs in men their fifties. The clinical manifestation manifested by symptoms of the lower urinary tract such as dysuria pollakiuria. Surgical management has been revolutionized advent trans-urethral resection prostate (TURP), which reference treatment.
 Objective: objective this work was to evaluat...

Objective: To evaluate the role of prostatic ultrasonography in predicting clinical outcomes bipolar transurethral resection prostate.Method: The prospective study was conducted at Urology Department, Kafrelsheikh University Hospital, Cairo, Egypt from December 2018 to June 2019, and comprised male patients complaining lower urinary tract symptoms due benign hyperplasia. were subjected pelvi-ab...

PURPOSE With the aim of evaluating the clinical significance of systematic prostate biopsy before transurethral resection of the prostate (TUR-P), clinical data were reviewed retrospectively in patients who had underwent prostate biopsy prior to scheduled TUR-P. PATIENTS AND METHODS Between July, 1994 and June, 2000, TUR-P was scheduled in a total number of 456 patients with clinically diagno...

PURPOSE We describe the trends in transurethral prostatectomy and minimally invasive surgical treatments for benign prostate hyperplasia from 1999 through 2005 among elderly male Medicare beneficiaries. MATERIALS AND METHODS Benign prostatic hyperplasia surgeries were identified using the annual 100% Medicare carrier files which contain physician claims for services reimbursed under Medicare ...

Background: Monopolar transurethral resection of prostate has long been a standard method of managements of benign prostatic hyperplasia. The safe and superior efficacy of transurethral resection of prostate (TURP) always argues strongly for maintaining it as the primary mode of therapy for patients with benign prostatic hyperplasia (BPH). There is a trend toward early catheter removal after tr...